Boni E. Elewski, M.D.



University of Alabama at Birmingham
EFH 414
1530 3RD AVE S
BIRMINGHAM AL 35294-0009

Office: (205)934-5188
Appointments: (205)996-7546 (SKIN)

Specialty:   Dermatology                                                                                         
Faculty Appointment:   Vice-Chair for Clinical Affairs
Professor of Dermatology


James E. Elder, MD, Endowed Professor for Graduate Education in
Director of Clinical Trials Research
Director, Fungal Reference Laboratory
Director, Residency Program

School of Medicine:   Ohio State University College of Medicine, 1978
Medical Internship:  

University of North Carolina Memorial Hospital, 1978 - 1979

Dermatology Residency:  

University of North Carolina Memorial Hospital, 1979-1982

Graduate Study:   University Medical Mycology Course, Duke Universiyt, 1981

Special Purposes Examination (SPEX), 1999
American Board of Dermatology, 1982
Diplomat National Board of Medical Examiners, 1979 

Clinical Interests:   President, American Academy of Dermatology, 2004-2005 Clinical Trials (including acne, actinic keratoses, cutaneous t-cell lymphoma, disseminated superficial actinic porokeratosis, eczema, epidermolysis bullosa, fungal infections, psoriasis, rosacea, seborrheic dermatitis), Cutaneous fungal infections, Fungal Reference Laboratory

Selected Publications

Guerrero CE, Elewski BE, Elmets CA. Treatment of nonmelanoma skin cancer. JAMA Intern Med. 2013 Dec 9;173(22):2096-7.

Pariser D, Elewski B, Rich P, Scher RK. Onychomycosis information for patients. Semin Cutan Med Surg. 2013 Jun;32(2 Suppl 1):2p. following S9-12.

Pariser D, Scher RK, Elewski B, Rich P. Promoting and maintaining or restoring healthy nails: practical recommendations for clinicians and patients. Semin Cutan Med Surg. 2013 Jun;32(2 Suppl 1):S13-4. Review.

Elewski B, Pariser D, Rich P, Scher RK. Current and emerging options in the treatment of onychomycosis. Semin Cutan Med Surg. 2013 Jun;32(2 Suppl 1):S9-12. Review.

Rich P, Elewski B, Scher RK, Pariser D. Diagnosis, clinical implications, and complications of onychomycosis. Semin Cutan Med Surg. 2013 Jun;32(2 Suppl 1):S5-8. Review.

Scher RK, Rich P, Pariser D, Elewski B. The epidemiology, etiology, and pathophysiology of onychomycosis. Semin Cutan Med Surg. 2013 Jun;32(2 Suppl 1):S2-4. Review.

Strober BE, Nyirady J, Mallya UG, Guettner A, Papavassilis C, Gottlieb AB, Elewski BE, Turner-Bowker DM, Shields AL, Gwaltney CJ, Lebwohl M. Item-level psychometric properties for a new patient-reported psoriasis symptom diary. Value Health. 2013 Sep-Oct;16(6):1014-22.

Elewski BE, Rich P, Tosti A, Pariser DM, Scher R, Daniel RC, Gupta AK. Onchomycosis: an overview. J Drugs Dermatol. 2013 Jul 1;12(7):s96-103. Carney C, Cantrell W,  Warner J, Elewski B. Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser. J Am Acad Dermatol. 2013 Oct;69(4):578-82.

Griffith JL, Ledet JJ, Elewski BE. Resident Rounds. Part III B: tumor necrosis factor-α antagonists and alopecia areata: a class-wide adverse effect. J Drugs Dermatol. 2013 Jun 1;12(6):713-4.

Stewart FA, Gavino AC, Elewski BE. New side effect of TNF-alpha inhibitors: morphea. Skinmed. 2013 Jan-Feb;11(1):59-60.

Mishra V, Daniel RC, Elmets CA, Levin A, Elewski BE. Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy. J Drugs Dermatol. 2013 Jan;12(1):16-7.

Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013 Apr;68(4):600-8.

Cathcart S, Sami N, Elewski B. Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors. J Drugs Dermatol. 2012 May;11(5):609-12.

Click here to view further publications on pubmed.